Targeted migration to damaged tissue

"Targeted migration to damaged tissue" refers to the process by which cells—most notably mesenchymal stem cells, immune cells, and progenitor cells—move directionally in response to molecular cues from sites of injury. This migration is primarily orchestrated by chemokine gradients (such as SDF-1/CXCL12), their receptors (like CXCR4, CCR2, and others), and downstream signaling cascades that cause cytoskeletal rearrangements facilitating movement[1][2][3][4][5][6][8]. The phenomenon is critical for tissue repair, inflammation, and regeneration, but is not itself a druggable molecular target—instead, discrete molecules in the process (such as CXCR4) are targeted therapeutically in certain contexts. If you require structured information for a specific receptor (for example, "CXCR4" or "CCR2") involved in this process, please specify the molecule or receptor name.

Other names

Directed cell migration to injuryHoming to damaged tissueCell trafficking to sites of injury

Modulation of chemokine gradients; Activation or inhibition of cell surface receptors (e.g., CXCR4, CCR1, CCR2) by specific ligands; Alteration of intracellular signaling pathways affecting actin cytoskeleton and cell movement